CLINICAL_TRIALS
trial_result
· 2018-10-11
Clinical Trial Update: Darbepoetin Alfa MDS Companion Protocol [Phase 3]
Summary
Phase 3 clinical trial update for darbepoetin alfa MDS companion protocol completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Myelodysplastic Syndrome (MDS) | Phase 3 | Status: COMPLETED | Results posted: 2018-10-11